Why Choose Us | NJ's #1 Urological Care & Treatment | Hackensack Meridian Health   

Why Choose Hackensack Meridian Health for Urology

Hackensack Meridian Health physicians and nurses provide patients with the most advanced and compassionate urology care in New Jersey and New York metro region. We specialize in a wide range of urologic disciplines, including urologic oncology, sexual dysfunction, infertility, stone disease, female urology and pediatric urology. 

Our urologists are known worldwide for excellence in robotic surgery, performing more than 5,000 procedures in the past decade.

 Robotic and Minimally Invasive Urology Surgery

Hackensack Meridian Health is a leader in providing robotic and minimally invasive surgery for urology. Across the network, we have eight dedicated robotic surgical systems, including the Da Vinci SP® single-port robot, which provides surgeons with a magnified view of the surgical area and a greater range of motion.

Each year, we perform more than 1,000 advanced urologic robotic surgery procedures, making us one of the most experienced hospital systems in the country. All bladder cancer surgeries can be performed robotically, and nearly all kidney cancer surgeries can be performed using minimally invasive techniques.

"We are one of the first 10 programs in the world to bring in the single-port robot...over the last 2 years we have performed over 600 surgeries." - Dr. Michael Stifelman, M.D. Chair of Urology HUMC

What Makes Us Leaders in Urology Care

The Department of Urology at Hackensack University Medical Center, a nationally ranked program by U.S. News & World Report, is renowned for its high-quality urologic care, including excellence in research and clinical outcomes.

  • Ranked #17 in the nation by U.S. News & World Report
  • Hackensack University Medical Center has been ranked the best Urology Program in New Jersey for eleven years in a row by U.S. News & World Report and ranked in the Top 20 nationally.
  • 6 subspecialties with fellowship-trained urologists
  • 2 Joint Commission Disease-Specific Care Certifications in prostate cancer and kidney cancer
  • 6 consecutive Magnet designations by the American Nurses Credentialing Center for nursing excellence
  • Awards & Accreditations
  • 30 IRB-approved protocols
  • 11 ongoing clinical trials:
    • 2 kidney cancer
    • 5 bladder cancer
    • 4 prostate cancer
  • 24 peer-reviewed publications in 2023
  • 16 research teams presented at national and international meetings in 2023
We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X